Skip to content

Clinical trials

Phase 1/2 Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1/2 Country / region: Taiwan Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20131
20141
20161
20174
20182
20193
20201
20211
20222
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting9
Terminated4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Merck Sharp & Dohme LLC2
AVEO Pharmaceuticals, Inc.1
Adherex Technologies, Inc.1
Amgen1
BioAtla, Inc.1
DualityBio Inc.1
Eisai Inc.1
Eli Lilly and Company1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms24
Carcinoma, Non-Small-Cell Lung11
Carcinoma7
Lung Neoplasms7
Neoplasms by Site5
Carcinoma, Hepatocellular4
Colorectal Neoplasms4
Head and Neck Neoplasms4
Lung Diseases4
Neoplasms by Histologic Type4

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.